stage

AIN
Medikamentenentwicklung

Medikamentenentwicklung

location_on Wien ,  Austria

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

Entwicklung eines breit wirksamen antiviralen Medikaments. Sensationeller Durchbruch bei der Bekämpfung von Viren! Medikamenten-Umsatz weltweit 53 Mdn $, diese bekämpfen nur einzelne Stämme. Viraus-Spray wirkt auf Covid, Sars, RSV, Influenza...

Highlights

  • exklusives anti-virales Medikament mit Breitenwirkung
  • Wortmarke "Viraus" angemeldet und internat. absicherbar
  • alle Experimente und Studien beweisen die breite Wirkung
  • prominenter Forscher mit Beteiligung der MedUni Wien

Overview

Target $950,000
Minimum $95,000
Investment Raised $0
Previous Rounds $0
Stage Pre-Startup/R&D
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects

Loading…
Loading the web debug toolbar…
Attempt #